null Option on Tourmaline Bio

TRML Stock   18.48  0.12  0.65%   
Tourmaline Bio's latest option contracts expiring on September 19th 2025 are carrying combined implied volatility of 1.5 with a put-to-call open interest ratio of 0.33 over 24 outstanding agreements suggesting investors are buying way more calls than puts on contracts expiring on September 19th 2025.

Open Interest Against September 19th 2025 Option Contracts

The chart above shows Tourmaline Bio's distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. Tourmaline Bio's open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for Tourmaline Bio's option, there is no secondary market available for investors to trade.

Tourmaline Bio Maximum Pain Price Across 2025-09-19 Option Contracts

Tourmaline Bio's max pain occurs when market makers reach a net positive position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthless.

In The Money vs. Out of Money Option Contracts on Tourmaline Bio

Analyzing Tourmaline Bio's in-the-money options over time can help investors to take a profitable long position in Tourmaline Bio regardless of its overall volatility. This is especially true when Tourmaline Bio's options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money Tourmaline Bio's options could be used as guardians of the underlying stock as they move almost dollar for dollar with Tourmaline Bio's stock while costing only a fraction of its price.

Tourmaline Bio In The Money Call Balance

When Tourmaline Bio's strike price is surpassing the current stock price, the option contract against Tourmaline Bio stock is said to be in the money. When it comes to buying Tourmaline Bio's options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on Tourmaline Bio are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.

Tourmaline Current Options Market Mood

Tourmaline Bio's open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Tourmaline Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.

Put-to-Call Open Interest

Put-to-Call Volume

Unfortunately, most Tourmaline Bio's options investors are not very successful. Tourmaline Bio's option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.

Rule 16 of the current Tourmaline contract

Base on the Rule 16, the options market is currently suggesting that Tourmaline Bio will have an average daily up or down price movement of about 0.0938% per day over the life of the 2025-09-19 option contract. With Tourmaline Bio trading at USD 18.48, that is roughly USD 0.0173. If you think that the market is fully incorporating Tourmaline Bio's daily price movement you should consider buying Tourmaline Bio options at the current volatility level of 1.5%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Purchasing Tourmaline Bio options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" Tourmaline calls. Remember, the seller must deliver Tourmaline Bio stock to the call owner when a call is exercised.

Tourmaline Bio Option Chain

When Tourmaline Bio's strike price is surpassing the current stock price, the option contract against Tourmaline Bio stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Tourmaline Bio's option chain is a display of a range of information that helps investors for ways to trade options on Tourmaline. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Tourmaline. It also shows strike prices and maturity days for a Tourmaline Bio against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone.
Open IntStrike PriceCurrent SpreadLast Price
Call
TRML250919C00040000040.00.0 - 5.05.0Out
Call
TRML250919C00035000935.00.0 - 4.94.9Out
Call
TRML250919C00030000230.00.0 - 2.952.95Out
Call
TRML250919C00025000025.00.0 - 2.052.05Out
Call
TRML250919C00022500022.50.1 - 4.90.1Out
Call
TRML250919C00020000220.00.55 - 4.90.55Out
Call
TRML250919C00017500317.51.85 - 4.62.75In
Call
TRML250919C000150004915.04.1 - 4.94.8In
Call
TRML250919C00012500212.55.8 - 8.55.7In
Call
TRML250919C00010000010.06.8 - 11.06.8In
Call
TRML250919C00007500107.510.4 - 13.59.8In
Call
TRML250919C0000250042.514.7 - 18.514.7In
 Put
TRML250919P00040000040.019.0 - 23.919.0In
 Put
TRML250919P00035000035.014.6 - 18.514.6In
 Put
TRML250919P00030000030.09.5 - 13.59.5In
 Put
TRML250919P00025000025.04.5 - 9.04.5In
 Put
TRML250919P00022500122.53.9 - 7.05.39In
 Put
TRML250919P00020000220.01.45 - 5.04.4In
 Put
TRML250919P00017500417.50.55 - 3.42.0Out
 Put
TRML250919P00015000315.00.0 - 4.72.49Out
 Put
TRML250919P00012500612.50.0 - 3.33.3Out
 Put
TRML250919P00010000510.00.0 - 0.950.95Out
 Put
TRML250919P0000750017.50.0 - 0.950.95Out
 Put
TRML250919P0000500055.00.0 - 4.94.9Out

Tourmaline Total Stockholder Equity

Total Stockholder Equity

315.05 Million

At this time, Tourmaline Bio's Total Stockholder Equity is quite stable compared to the past year.

Tourmaline Bio Corporate Management

Susan JonesChief OfficerProfile
Kimberly PiorkowskiCulture PeopleProfile
Bradford JDGeneral OfficerProfile
Dr MBAChief OfficerProfile
Emil MDSenior ResearchProfile
Yung MDChief OfficerProfile
When determining whether Tourmaline Bio is a strong investment it is important to analyze Tourmaline Bio's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Tourmaline Bio's future performance. For an informed investment choice regarding Tourmaline Stock, refer to the following important reports:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Tourmaline Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
For more information on how to buy Tourmaline Stock please use our How to buy in Tourmaline Stock guide.
You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Tourmaline Bio. If investors know Tourmaline will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Tourmaline Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(3.23)
Return On Assets
(0.19)
Return On Equity
(0.26)
The market value of Tourmaline Bio is measured differently than its book value, which is the value of Tourmaline that is recorded on the company's balance sheet. Investors also form their own opinion of Tourmaline Bio's value that differs from its market value or its book value, called intrinsic value, which is Tourmaline Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Tourmaline Bio's market value can be influenced by many factors that don't directly affect Tourmaline Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Tourmaline Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Tourmaline Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tourmaline Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.